67 filings
Page 4 of 4
8-K
5wpqhah d6sx5rwb12
24 Jun 19
Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 In Galactosemia
7:09am
8-K
mqvazatgyr
21 Jun 19
Applied Therapeutics Reports First Quarter 2019 Financial Results
7:34am
8-K
lsofi6pa0 m50yytlq
7 Jun 19
AT-001, a novel, potent and selective aldose reductase inhibitor, is expected to start a pivotal study later this year
7:59am
8-K
ftnzjwoj2
6 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
zc0 0ijfsmfw28
28 May 19
Applied Therapeutics Announces Fda Orphan Drug Designation for AT-007 In Galactosemia
5:14pm
8-K
su4j4zd8n e0di
24 May 19
Other Events
4:24pm
8-K
n2on2 wflnx8yq
16 May 19
Amendments to Articles of Incorporation or Bylaws
5:22pm